Allahabad HC Reduces Cop's Sentence in 1984 Attempt-to-Murder Case, Awards Rs. 35,000 to Victim  ||  Delhi High Court: Copyright Owners and ISPs Cannot Unilaterally Declare a Website 'Rogue'  ||  Rajasthan HC: Teacher's Reprimand for Poor Attendance and Performance is Not Abetment of Suicide  ||  Karnataka High Court: Police Assistance to Enforce Injunction Not Barred by Res Judicata  ||  SC Upholds Validity of Section 16(2)(c) of CGST Act, Says ITC Depends on Supplier's Tax Payment  ||  Supreme Court: Registration Certificate Alone Can't Secure Interim Release of Seized Vehicles  ||  Supreme Court: IBC Moratorium Doesn't Shield Promoters, Directors From Consumer Complaints  ||  Supreme Court: Accused Person's Advocate Cannot Remain Present During Entire Police Interrogation  ||  Uttarakhand HC: Severity of POCSO Charges Alone Cannot Deny Juvenile Bail  ||  Madras HC Grants Anticipatory Bail to Man Accused of Watching CM Vijay's Unreleased Film Online    

Finalization of Draft Rules on Sale of Drugs by E-Pharmacies- (Press Information Bureau) (25 Jun 2019)

MANU/PIBU/0667/2019

Law of Medicine

The Government has published draft rules vide G.S.R. 817 (E) dated 28th August 2018 for inviting public/stakeholder comments for amendment to the Drugs and Cosmetics Rules, 1945 for incorporating provisions relating to regulation of sale and distribution of drugs through e-pharmacy. A large number of suggestions/comments have been received from the stakeholders, which are being examined. At the same time, the matter is sub-judice before various Hon'ble High Courts in the country. Therefore, no timeline for finalization of the rules can be provided.

Under the Drugs & Cosmetics Act and Rules, sale of spurious drugs is a punishable offence and State Licensing Authorities are empowered to take action in this regard. Accordingly, the complaints as received, are referred to State Licensing Authorities for taking action as per the provisions of the Act and Rules.

Tags : DRAFT RULES   FINALIZATION   SALE OF DRUGS   E-PHARMACIES  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved